Luminus Diagnostics, LLC

Luminus Diagnostics, LLC was paid $572K by Medicaid between Jan 2018 and Apr 2022, across 95 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 42% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Georgia

Rank by total paid#28 of 66

Median peer was paid$178K

This provider vs. median3.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	5,543	$18K
2019	5,261	$17K
2020	15,266	$149K
2021	33,490	$347K
2022	4,811	$41K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	42%	12,593	4,732	$241K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	18%	3,366	1,960	$103K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	8.6%	6,143	2,218	$49K
87481		5.4%	2,510	1,957	$31K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	3.4%	2,012	1,686	$20K
80361		3.4%	291	256	$19K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	1.9%	709	672	$11K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	1.7%	2,522	1,967	$10K
87653		1.6%	2,508	1,955	$9K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	1.5%	650	578	$9K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	1.5%	909	787	$8K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	1.3%	868	555	$8K

83 more codes

87500		1.3%	2,329	$7K
87641		1.2%	2,318	$7K
87640		1.1%	1,848	$7K
87556		<1%	2,116	$4K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	<1%	2,655	$3K
87561		<1%	2,118	$3K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	482	$2K
87563		<1%	970	$2K
84443	Thyroid stimulating hormone (TSH)	<1%	655	$2K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	248	$2K
80053	Comprehensive metabolic panel	<1%	895	$1K
80061	Lipid panel	<1%	600	$1K
87529		<1%	22	$1K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	895	$977.82
83036	Hemoglobin; glycosylated (A1C)	<1%	538	$780.51
87625		<1%	22	$687.11
87496		<1%	53	$666.18
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	53	$666.08
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	93	$664.00
82607		<1%	340	$608.57
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	22	$595.19
36415	Collection of venous blood by venipuncture	<1%	1,228	$483.66
80346		<1%	183	$463.50
87631		<1%	19	$425.04
87511		<1%	16	$421.08
87532		<1%	14	$350.90
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	<1%	418	$320.36
83719		<1%	96	$258.60
87086	Culture, bacterial; quantitative colony count, urine	<1%	190	$223.20
83721		<1%	97	$212.00
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	365	$196.20
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	28	$191.60
83992		<1%	295	$141.02
87634		<1%	28	$140.40
81001		<1%	248	$122.16
82570		<1%	27	$91.25
80336		<1%	269	$81.00
80372		<1%	275	$76.50
80354		<1%	275	$76.50
80365		<1%	292	$76.50
80364		<1%	274	$76.50
80373		<1%	290	$76.50
80348		<1%	290	$76.50
80356		<1%	291	$76.50
84439		<1%	66	$76.44
80371		<1%	276	$74.25
80349		<1%	291	$74.25
80350		<1%	276	$74.25
80368		<1%	269	$74.25
80358		<1%	276	$74.25
80360		<1%	283	$74.25
80338		<1%	202	$74.25
87498		<1%	29	$70.18
87581		<1%	28	$70.18
87541		<1%	28	$70.18
87486		<1%	28	$70.18
80359		<1%	275	$69.75
80353		<1%	291	$69.75
83986		<1%	27	$68.90
82172		<1%	76	$64.00
80370		<1%	242	$59.40
87503		<1%	28	$56.52
80323		<1%	127	$44.55
80334		<1%	31	$44.55
87551		<1%	14	$42.99
83880		<1%	29	$39.51
80333		<1%	135	$29.70
80375		<1%	117	$29.70
80326		<1%	117	$27.90
80339		<1%	135	$27.00
80345		<1%	250	$21.60
87186		<1%	17	$10.67
87088		<1%	17	$9.99
87076		<1%	17	$9.97
80048	Basic metabolic panel (calcium, ionized)	<1%	13	$8.69
84436		<1%	17	$8.48
80188		0%	72	$0.00
80324		0%	15	$0.00
85027		0%	17	$0.00
80325		0%	106	$0.00
80321		0%	101	$0.00
80355		0%	86	$0.00
80366		0%	86	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGAMAGE, LAUREL (MANAGER)